Variable | Control (number = 49) | EPO (number = 49) | P value |
---|---|---|---|
Age (years) | 62 ± 10 | 63 ± 10 | 0.880 |
Female | 24 (49) | 20 (41) | 0.417 |
BMI (kg/m2) | 24 ± 4 | 24 ± 3 | 0.528 |
Operation | Â | Â | Â |
   MVR + TAP | 6 (12) | 8 (16) | 0.564 |
   Multi valve | 22 (45) | 20 (41) | 0.683 |
   Valve + CABG | 8 (16) | 7 (14) | 0.779 |
   Bentall | 13 (27) | 14 (29) | 0.821 |
   Redo | 6 (12) | 4 (8) | 0.505 |
NYHA | Â | Â | Â |
   I-II | 42 (86) | 43 (88) | 0.766 |
   III-IV | 7 (14) | 6 (12) |  |
EuroSCORE | 5.1 ± 2.6 | 5.7 ± 2.5 | 0.299 |
DM | 8 (16) | 16 (33) | 0.060 |
Hypertension | 24 (49) | 27 (55) | 0.544 |
Chronic kidney disease | 14 (29) | 10 (20) | 0.347 |
Chronic obstructive lung disease | 2 (4) | 0 (0) | 0.495 |
Ejection fraction (%) | 60 ± 13 | 60 ± 12 | 0.798 |
Preoperative eGFR | 77 ± 30 | 83 ± 28 | 0.378 |
Preoperative CrCl <60Â ml/min | 21 (43) | 17 (35) | 0.407 |
Medication | Â | Â | Â |
   β-blockers | 18 (38) | 14 (29) | 0.350 |
   CCB | 17 (35) | 13 (27) | 0.344 |
   ACEi | 17 (35) | 12 (25) | 0.240 |
   ARB | 16 (33) | 13 (27) | 0.464 |
   Diuretics | 28 (58) | 28 (57) | 0.906 |
Preoperative hematocrit (%) | 38 ± 6 | 39 ± 4 | 0.375 |